Search the Newsreel

Haleon plc (HLN) Investor Outlook: Exploring a 19.58% Potential Upside in the Healthcare Giant

Haleon plc (HLN), a leader in consumer healthcare with a $44.17 billion market cap, is poised for a potential upside of 19.58%. The company demonstrates stable financial health with modest revenue growth, efficient management, and a balanced dividend yield. Favorable analyst ratings, positive technical …

Earnings call transcript: Hallador Energy Q2 2026 EPS miss, stock slips after hours

Key Points Interested in Hallador Energy Company? Here are five stocks we like better. Q2 profitability declined sharply: Hallador reported a $15.2 million net loss and negative $2.9 million adjusted EBITDA, pressured by a 60-day Merom maintenance outage, reliability work and costly power purchases. …

Hallador Energy (HNRG) Reports Q2 Loss, Beats Revenue Estimates

Hallador Energy (Nasdaq: HNRG) posts loss as outages hit power unit, pursues $350M turbine deal

Hallador Energy (HNRG) reported a net loss of $24.6 million for the first half of 2026, a significant drop from a net income of $18.2 million in the prior year, primarily due to outages at its Merom power plant and lower Electric Operations revenue. …

Hallador Energy (NASDAQ:HNRG) Announces Quarterly Earnings Results, Misses Estimates By $0.20 EPS

Hallador Energy (NASDAQ:HNRG) reported a quarterly EPS loss of $0.32, missing analyst estimates by $0.20, despite revenue of $101.51 million which exceeded expectations. Following the announcement, shares rose 7.6% to $15.88. Analysts maintain a "Moderate Buy" rating with a $26.62 price target, and insider …

Hallador Energy (NASDAQ: HNRG) swings to Q2 loss but trims Turtle Creek gas project cost

Halozyme Therapeutics (HALO) insider schedules 1,626-share stock sale via trading plan

Halozyme Therapeutics insider Bernadette Connaughton plans to sell 1,626 shares of common stock, valued at $167,673.12, through Morgan Stanley Smith Barney LLC on August 10, 2026. These shares originated from Restricted Stock Units granted in April 2025. The filing also details prior sales under …

Hallador Energy: Q2 Earnings Snapshot

Hallador Energy (NASDAQ:HNRG) Stock Price Up 8.8% - Should You Buy?

Halliburton Co. stock outperforms competitors on strong trading day

Halliburton Co. (HAL) stock advanced 5.49% to $33.64 on a day when the broader market, including the S&P 500 and Dow Jones Industrial Average, experienced declines. Despite the strong performance, Halliburton Co. closed 22.83% below its 52-week high of $43.59. This positive movement indicates …

Halliburton Company (HAL) Stock forecasts

This article provides a stock forecast for Halliburton Company (HAL), highlighting its position as North America's largest oilfield-services company. The report, authored by Morningstar's Joshua Aguilar, details Halliburton's leading market share in hydraulic fracturing and completions, which accounts for nearly half of its revenue. …

Challenger Gold (ASX:CEL) Rallies As Fresh Capital Supports Hualilan Growth

Price to earnings forward of Al Khaleej Training & Education Co. – TADAWUL:4290

Marshalls (LON:MSLH) Releases Earnings Results

Marshalls (LON:MSLH) Given Buy Rating at Peel Hunt

Marshalls H1 Earnings Call Highlights

Marshalls (LON:MSLH) reported broadly flat first-half revenue of £380 million as weak activity in new housing and private housing repair, maintenance and improvement markets continued to weigh on volumes. However, operating profit rose 8% to £30.7 million, supported by improved profitability in its Landscaping …

Gradient Investments LLC Makes New Investment in Halozyme Therapeutics, Inc. $HALO

Gradient Investments LLC has purchased a new stake in Halozyme Therapeutics, Inc. ($HALO), acquiring 16,437 shares valued at approximately $1.29 million. This investment comes as Halozyme reported a strong second quarter with significant revenue growth and raised its 2026 guidance, attracting positive analyst sentiment. …

Earnings Update: Halozyme Therapeutics, Inc. Beat Earnings And Now Analysts Have New Forecasts For This Year

Halozyme Therapeutics, Inc. reported a strong quarter, exceeding analysts' earnings expectations. Following these results, analysts have updated their financial forecasts for the current year, indicating a positive outlook for the company's performance. This update reflects increased confidence in Halozyme's financial trajectory.

Marshalls plc Reports Earnings Results for the Half Year Ended June 30, 2026

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: A Biotech Powerhouse with Robust Revenue Growth and Strong Analyst Support

California State Teachers Retirement System Grows Stock Holdings in Robert Half Inc. $RHI

The California State Teachers Retirement System increased its stake in Robert Half Inc. (NYSE:RHI) by 25% in the first quarter, bringing its total holdings to 119,848 shares valued at $3.04 million. Institutional investors collectively own 92.41% of the company. Despite reporting quarterly revenue of …

Marshalls Shares Slide Despite Profit Growth as Outlook Stays Cautious

UK's Marshalls reports higher profit on cost cuts, says market recovery unlikely in 2026

John Marshall Bancorp Inc (JMSB) Earnings Forecast: Future EPS & Revenue Growth Estimates

John Marshall Bancorp Inc (JMSB) has an earnings forecast score of 9.00, placing it 6th out of 395 in the Banking Services industry. Analysts have set an average target price of $23.00 for JMSB, with 2 analysts issuing a "Strong Buy" rating. The company's …

HALEOSLABS Standalone June 2026 Net Sales at Rs 67.83 crore, down 14.19% Y-o-Y

Marshalls reports first-half revenue decline amid weak demand By Investing.com

Earnings Flash (MSLH.L) Marshalls PLC Posts H1 EPS GBX5.9

REG - Marshalls PLC - Half-year results

Hindustan Aeronautics Limited (NSE:HAL) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

Haleon PLC Sponsored ADR (NYSE:HLN) Given Average Rating of "Moderate Buy" by Brokerages

Haleon PLC Sponsored ADR (NYSE:HLN) has received a consensus "Moderate Buy" rating from ten brokerages. While some firms upgraded the stock, others downgraded or maintained neutral views. The company recently declared a quarterly dividend of $0.0642 per share, and institutional investors have significantly modified …

Halma plc (HLMAF) stock price, news, quote and history

Robert Half Stock And 2 US Compliance Services Picks For Tariff Refund Demand

Where Does Charter Hall Retail REIT (ASX:CQR) Valuation Sit Following Its FY26 Results?

Halozyme Therapeutics (HALO) Is Up 24.9% After Record Q2, Higher 2026 Guidance And New ENHANZE Deals - Has The Bull Case Changed?

Halozyme Therapeutics reported record second-quarter results with revenue up to US$481 million and net income of US$229.91 million, leading to increased full-year 2026 revenue guidance. The company also accelerated share buybacks and secured new ENHANZE collaborations, reinforcing its royalty-led business model. While these achievements …

Haleon plc (LON:HLN) Passed Our Checks, And It's About To Pay A UK£0.024 Dividend

Shalfa Facilities Management Logs Surge in H1 Net Profit; Revenue Up